Mode
Text Size
Log in / Sign up

Cardiology

835 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Systematic review and meta-analysis reports 36.6% cognitive impairment prevalence in coronary heart disease patients
Cardiology Meta-analysis
Systematic review and meta-analysis reports 36.6% cognitive impairment prevalence in coronary heart disease patients Older patients with heart disease and stroke history face higher risk of thinking problems
This systematic review and meta-analysis evaluates risk factors for cognitive impairment in patients with coronary heart disease. The pooled…
A large study found that nearly 37% of patients with heart disease have cognitive issues. Age, past strokes, and smoking all increase this r…
Individual patient data meta-analysis links myocardial injury categories to cardiovascular event risk
Cardiology Meta-analysis
Individual patient data meta-analysis links myocardial injury categories to cardiovascular event risk Heart Attack Risk: New Classification Changes Everything for Patients
This individual patient-level data meta-analysis of 120,734 patients from 9 countries evaluated myocardial injury and infarction categories.…
A new way of classifying heart attacks reveals that patients with type 2 heart attacks face a surprisingly higher risk of dying from non-hea…
Meta-analysis links elevated GDF-15 to mortality in acute heart failure
Cardiology Meta-analysis
Meta-analysis links elevated GDF-15 to mortality in acute heart failure Heart Failure Patients With High Stress Marker Face Triple Death Risk
This meta-analysis of 3724 adult acute heart failure patients found that elevated admission GDF-15 levels were significantly associated with…
• High blood stress levels triple death risk during hospital stays • Helps doctors spot heart failure patients needing urgent care • Not yet…
Meta-analysis finds no significant difference in target-lesion failure between bioadaptor and DES at 1 year
Cardiology Meta-analysis
Meta-analysis finds no significant difference in target-lesion failure between bioadaptor and DES at 1 year New Heart Stent May Lower Late Problems After First Year
This meta-analysis of randomized trials compared a bioadaptor with drug-eluting stents in 2892 patients undergoing PCI. At 1 year, target-le…
A new heart stent that uncages after six months shows low late problem rates compared to standard stents.
Tailored antiplatelet strategy showed no benefit over standard dual therapy in high-risk PCI patients
Cardiology RCT
Tailored antiplatelet strategy showed no benefit over standard dual therapy in high-risk PCI patients New heart drug plan failed to beat standard care for high-risk patients
This randomized clinical trial compared a tailored antiplatelet strategy involving early low-dose ticagrelor followed by late de-escalation …
Doctors tested a custom heart drug plan but found standard treatment still works best for high-risk patients
CABG versus PCI in high-risk coronary revascularisation patients shows mixed outcomes over 5 years
Cardiology RCT
CABG versus PCI in high-risk coronary revascularisation patients shows mixed outcomes over 5 years New Surgery Options For High-Risk Heart Patients
This observational study emulation of 103,670 people requiring multivessel revascularisation compared CABG and PCI. Over 5 years, CABG showe…
New data shows heart surgery and stents work differently for older patients with kidney disease or heart failure.
Transcatheter valve replacement improves outcomes in severe tricuspid regurgitation
Cardiology RCT
Transcatheter valve replacement improves outcomes in severe tricuspid regurgitation New Valve Fix Cuts Hospital Stays for Severe Heart Leak Patients
A randomized trial shows EVOQUE TTVR plus medical therapy outperforms medical therapy alone for severe tricuspid regurgitation, improving va…
A new minimally invasive valve replacement slashes hospital stays for severe heart leak patients especially those with the worst cases new l…
Meta-analysis links TNF pathway proteins to ischemic stroke risk and recurrence
Cardiology Meta-analysis
Meta-analysis links TNF pathway proteins to ischemic stroke risk and recurrence Higher TNF proteins linked to increased stroke risk in large study
This meta-analysis of observational cohorts synthesizes evidence that circulating TNF pathway proteins are associated with incident and recu…
People with more TNF proteins in their blood had a higher chance of having a stroke. This was seen in two large groups of adults.
FDA Approves Crestor (rosuvastatin) for Cardiovascular Risk Reduction in Adults
Cardiology FDA Approval
FDA Approves Crestor (rosuvastatin) for Cardiovascular Risk Reduction in Adults FDA approves Crestor to prevent heart attacks and strokes in certain adults.
FDA approved Crestor (rosuvastatin) to reduce risk of major adverse cardiovascular events in adults without established coronary heart disea…
The FDA approved Crestor (rosuvastatin) to reduce the risk of heart attack, stroke, and related events in adults without heart disease but w…
Systematic review finds CCTA underestimates SYNTAX scores versus invasive angiography in coronary artery disease
Cardiology Meta-analysis
Systematic review finds CCTA underestimates SYNTAX scores versus invasive angiography in coronary artery disease Heart Scans May Miss Key Details About Artery Blockages
This systematic review and meta-analysis evaluated coronary CT angiography (CCTA) against invasive coronary angiography (ICA) in adult popul…
A common non-invasive heart scan may underestimate how severe your artery blockages really are, which could change whether you need a stent …
Omecamtiv mecarbil shows trend toward reduced serious arrhythmia risk in HFrEF post hoc analysis
Cardiology RCT
Omecamtiv mecarbil shows trend toward reduced serious arrhythmia risk in HFrEF post hoc analysis Heart Drug Shows Promise Against Deadly Heart Rhythms
This post hoc analysis of a randomized controlled trial evaluated omecamtiv mecarbil versus placebo in 8232 participants with symptomatic ch…
A heart failure medication already shown to improve pumping strength may also protect against sudden cardiac arrest, especially in patients …
Beta-blocker therapy in AMI patients with preserved ejection fraction shows comparable outcomes to non-use
Cardiology Meta-analysis
Beta-blocker therapy in AMI patients with preserved ejection fraction shows comparable outcomes to non-use New analysis shows beta-blockers do not lower heart attack risks for most patients with strong hearts
This meta-analysis of randomized controlled trials evaluated beta-blocker therapy in 19,826 patients with acute myocardial infarction and pr…
A large study of nearly twenty thousand patients found that taking beta-blockers after a heart attack did not reduce the risk of dying or ha…